Durmus, MTurkoz, ATogal, TKoroglu, AToprak, HIErsoy, MO2024-08-042024-08-0420020265-02151365-2346https://doi.org/10.1017/S0265021502241356https://hdl.handle.net/11616/104019[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keywords]Remifentanil and acute intermittent porphyriaLetter19118398401244293810.1017/S0265021502241356WOS:000179377300014Q2